We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

386:HKEXChina Petroleum & Chemical Corporation Class H Analysis

Data as of 2026-05-26 - not real-time

¥1,348.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 1,348 JPY, just above the 20‑day SMA of 1,328 but still under the 50‑day SMA of 1,378. It sits far below the 200‑day SMA of 1,748, underscoring a bearish longer‑term trend. The 14‑day RSI of 51.7 places the stock in a neutral zone, offering limited upside bias. A positive MACD histogram of 5.5 points to emerging short‑term momentum. Current price remains above the identified support level of 1,293 JPY, while resistance sits near 1,426 JPY. Trading volume is on an upward trajectory, supporting the technical signal. The beta of 0.29 suggests low sensitivity to market swings, yet 30‑day volatility is elevated at 21.9%, indicating price swings can be sharp.
On the fundamentals side, revenue of roughly ¥25.3 bn grew 5.7% YoY, but margins are thin with a gross margin of 37.7% and a profit margin of only 1.2%. Operating margin sits at 4.8%, reflecting modest cost control. The trailing PE of 19× and price‑to‑book of 1.24 position the stock near fair value relative to peers. A dividend yield of 3.73% is attractive, yet the reported payout ratio of 0% raises questions about sustainability. The balance sheet shows a debt‑to‑equity ratio of 53.9% and cash reserves that are slightly lower than total debt, adding a modest financial risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above immediate support (1293 JPY)
  • Positive MACD histogram indicating short‑term momentum
  • Attractive dividend yield of 3.73%

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Bearish position relative to 200‑day SMA
  • Thin profit margins and uncertain dividend sustainability
  • Moderate debt level with cash slightly below debt

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Fair valuation metrics (PE ~19, P/B 1.24)
  • Potential for dividend income if sustainability improves
  • Low beta suggesting defensive profile in a consumer cyclical niche

Key Metrics & Analysis

Financial Health

Revenue Growth5.70%
Profit Margin1.17%
P/E Ratio19.0
Debt/Equity53.92
P/B Ratio1.2

Technical Analysis

TrendBearish
RSI51.7
Support¥1,293.00
Resistance¥1,426.00
MA 20¥1,328.55
MA 50¥1,377.54
MA 200¥1,747.96
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

GradeFair
TypeBlend
Dividend Yield3.73%

Risk Assessment

Beta0.29
Volatility21.90%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.